Curaleaf Opens Boston Dispensary Near Downtown Crossing, Expanding Access for Patients in Massachusetts

New location features expanded retail space, enhanced product selection and convenient
access in the heart of Boston

STAMFORD, Conn., Sept. 2, 2026 /PRNewswire/ -- Curaleaf Holdings, Inc. (TSX: CURA) (OTCQX: CURLF) ("Curaleaf"), a leading international provider of consumer cannabis products, today announced the opening of its newest Massachusetts dispensary in downtown Boston on Friday, September 4. Located at 21 Milk St., Boston, MA 02109, the new dispensary provides patients throughout Boston and the surrounding region with convenient access to premium cannabis products, an expanded storefront, and a broader product selection.

Situated near Boston's vibrant mix of local businesses, restaurants and coffee shops near Downtown Crossing, Curaleaf Boston provides patients with a welcoming and convenient retail experience designed to serve both new and experienced cannabis consumers.

"Boston is a dynamic market with a thriving cannabis community, and we are excited to strengthen our presence in the city with the opening of Curaleaf Boston," said Boris Jordan, Chairman and Chief Executive Officer of Curaleaf. "This new location gives us an opportunity to provide consumers a greater product selection, a more expansive retail environment and the quality, education and service they have come to expect from Curaleaf. We look forward to becoming part of the Boston community and serving customers from across the city and beyond."

Patients at Curaleaf Boston will have access to Curaleaf's extensive portfolio of trusted cannabis brands, including Dark Heart, Select, FIND, Anthem and Grassroots. The dispensary will also feature the Select Briq 2 all-in-one vape device, including products from the Select Live Collection, designed for patients seeking a deeper connection to the plant. Curaleaf's knowledgeable team members are available to help customers navigate product options and identify products tailored to their individual needs.

A grand opening celebration will take place at Curaleaf Boston on Tuesday, September 8, featuring special in-store promotions, a Meet the Grower event, third-party vendors, and brand activations. Additional details will be announced through Curaleaf's social media channels and patient communications. The store will operate from 9:00 A.M. to 8:00 P.M. ET Monday through Saturday, and 9:00 A.M. to 6:00 P.M. ET on Sunday.

The opening of Curaleaf Boston follows the closure of the company's former Provincetown dispensary and reflects Curaleaf's continued investment in providing convenient access to high-quality cannabis products and experiences throughout Massachusetts.

For more information about Curaleaf, including store locations and product availability, visit Curaleaf.com.

About Curaleaf Holdings

Curaleaf Holdings, Inc. (TSX: CURA) (OTCQX: CURLF) ("Curaleaf") is a leading international provider of consumer products in cannabis with a mission to enhance lives by cultivating, sharing and celebrating the power of the plant. As a high-growth cannabis company known for quality, expertise and reliability, the Company and its brands, including Curaleaf, Select, Grassroots, Find, Dark Heart, and Anthem provide industry-leading service, product selection and accessibility across the medical and adult use markets. Curaleaf International is powered by a strong presence in all stages of the supply chain. Its unique distribution network throughout Europe, Canada and Australasia brings together pioneering science and research with cutting-edge cultivation, extraction and production. Curaleaf is listed on the Toronto Stock Exchange under the symbol CURA and trades on the OTCQX market under the symbol CURLF. For more information, please visit https://ir.curaleaf.com.

Forward Looking Statements

This media advisory contains forward-looking statements and forward-looking information within the meaning of applicable securities laws. These statements relate to future events or future performance. All statements other than statements of historical fact may be forward–looking statements or information. Generally, forward-looking statements and information may be identified by the use of forward-looking terminology such as "plans", "expects" or "proposed", "is expected", "intends", "anticipates", or "believes", or variations of such words and phrases, or by the use of words or phrases which state that certain actions, events or results may, could, would, or might occur or be achieved. More particularly and without limitation, this news release contains forward-looking statements and information concerning the opening of a dispensary in Boston, Massachusetts. Such forward-looking statements and information reflect management's current beliefs and are based on assumptions made by and information currently available to the company with respect to the matter described in this new release. Forward-looking statements involve risks and uncertainties, which are based on current expectations as of the date of this release and subject to known and unknown risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such statements. Additional information about these assumptions and uncertainties is discussed in the Company's Form 8-K dated August 5, 2026 together with the annual report on Form 10-K for the year ended December 31, 2025 and the quarterly report on Form 10-Q for the quarter ended March 31, 2026, attached as exhibits thereto, as well as the Form 10-Q for the quarter ended June 30, 2026, each of which documents have been filed on the Company's EDGAR profile at www.sec.gov/edgar and SEDAR+ profile at www.sedarplus.ca, and as described from time to time in documents filed by the Company with the U.S. Securities and Exchange Commission and the Canadian securities regulatory authorities. Forward-looking statements contained herein are made only as to the date of this press release and we undertake no obligation to update or revise any forward-looking statements whether as a result of new information, future events or otherwise, except as required by law. We caution investors not to place considerable reliance on the forward-looking statements contained in this press release. The Toronto Stock Exchange has not reviewed, approved or disapproved the content of this news release.

Investor Contact:
Curaleaf Holdings, Inc.
Camilo Lyon, Chief Investment Officer
[email protected]

Media Contact:
MATTIO Communications
[email protected]

SOURCE Curaleaf Holdings, Inc.